Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
MDNAF
Fundamentals

Medicenna Therapeutics Corp.

MDNAF

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

36.45M
▲12.99M▲55.38%
12 Months Change

Liabilities

6.96M
▲4.34M▲165.55%
12 Months Change

Free Cash Flow

0.00
0.000.00%
-

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2023-06-27
Form 20-F
ID: 0001171843-23-004170
2022-06-22
Form 20-F
ID: 0001171843-22-004481
2021-05-28
Form 40-F
ID: 0001171843-21-003878